Edgar Filing: ANDREACIO JOHN

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â ANDREACIO JOHN

2. Date of Event Requiring Statement (Month/Day/Year)
01/18/2018

3. Issuer Name and Ticker or Trading Symbol
1ST CONSTITUTION BANCORP [FCCY]

(Last)

(First)

(Middle)

C/O 1ST CONSTITUTION BANCORP,Â 2650 ROUTE 130

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)
Chief Lending Officer and EVP

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

CRANBURY,Â NJÂ 08512

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	18,711 ⁽¹⁾	D	Â
Common Stock	1,022	I	By 401(k) ⁽²⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock option (right to buy)	Â ⁽³⁾	01/06/2024	Common Stock	221	$ 10.24	D	Â
Stock option (right to buy)	Â ⁽⁴⁾	01/02/2025	Common Stock	442	$ 10.1	D	Â
Stock option (right to buy)	Â ⁽⁵⁾	01/04/2026	Common Stock	630	$ 11.98	D	Â
Stock option (right to buy)	Â ⁽⁶⁾	01/03/2027	Common Stock	1,000	$ 18.65	D	Â
Stock option (right to buy)	Â ⁽⁷⁾	01/02/2028	Common Stock	1,000	$ 18.3	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
ANDREACIO JOHN C/O 1ST CONSTITUTION BANCORP 2650 ROUTE 130 CRANBURY,Â NJÂ 08512	Â	Â	Â Chief Lending Officer and EVP	Â

Signatures

/s/ Ellen S. Knarr as Attorney-in-fact for John T. Andreacio		01/29/2018
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Amount includes 1,102 restricted shares scheduled to vest on September 18, 2018; 1,313 restricted shares scheduled to vest on July 16, 2018; 1,312 restricted shares scheduled to vest on July 16, 2019; 263 restricted shares scheduled to vest on January 4, 2019; 262 restricted shares scheduled to vest on January 4, 2020; 2,375 restricted shares scheduled to vest on July 28, 2018; 2,375 restricted shares scheduled to vest on July 28, 2019; 2,375 restricted shares scheduled to vest on July 28, 2020; 250 restricted shares scheduled to vest on January 3, 2019; 250 restricted shares scheduled to vest on January 3, 2020; 250 restricted shares scheduled to vest on January 3, 2021; 1,000 restricted shares scheduled to vest on July 28, 2021; 250 restricted shares scheduled to vest on January 2, 2019; 250 restricted shares scheduled to vest on January 2, 2020; 250 restricted shares scheduled to vest on January 2, 2021; and 250 restricted shares scheduled to vest on January 2, 2022.
(2)	Information presented as of the close of business on January 29, 2018.
(3)	All options are exercisable.
(4)	Of these stock options, 221 are vested and exercisable and 221 options are scheduled to vest on January 2, 2019.
(5)	Of these stock options, 210 are vested and exercisable, 210 are scheduled to vest on January 4, 2019 and 210 are scheduled to vest on January 4, 2020.
(6)	Of these stock options, 400 are vested and exercisable, 200 are scheduled to vest on January 3, 2019, 200 are scheduled to vest on January 3, 2020 and 200 are scheduled to vest on January 3, 2021.
(7)	Of these stock options, 200 are vested and exercisable, 200 are scheduled to vest on January 2, 2019, 200 are scheduled to vest on January 2, 2020, 200 are scheduled to vest on January 2, 2021 and 200 are scheduled to vest on January 2, 2022.
Â Remarks: ExhibitÂ ListÂ ExhibitÂ 24Â --Â PowerÂ ofÂ Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.